Zobrazeno 1 - 10
of 59
pro vyhledávání: '"J.E. Ang"'
Autor:
I.G. Funingana, E. Leung, M-L. Alcaraz, L. Bird, J.E. Ang, C. Parkinson, M. Jimenez-Linan, S. Freeman, C. Spencer, J. Winning, R. Ganesan, S. Williams, K.R. Ong, P. Abedin, S. Sundar, J. Balega, J.D. Brenton
Publikováno v:
Annals of Oncology. 33:S397
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fd2f4a577fcc2811fccd921c91cfa84
https://doi.org/10.1016/j.annonc.2022.04.051
https://doi.org/10.1016/j.annonc.2022.04.051
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David S.P. Tan, Susana Banerjee, Margaret Hutka, Ewa Grzybowska, Timothy A. Yap, Stan B. Kaye, Charlie Gourley, Martin Gore, Patricia Roxburgh, J.E. Ang
Publikováno v:
European Journal of Cancer. 49:1246-1253
Introduction: Preclinical data suggest that BRCA1 and BRCA2 (BRCA1/2)mutated ovarian cancers (BMOC) are exquisitely sensitive to platinum-salts, but resistant to microtubule-stabilizing anticancer agents. The clinical relevance of these preclinical d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c985adccbfe89611a7e322a7f4c88907
https://doi.org/10.1016/j.ejca.2012.11.016
https://doi.org/10.1016/j.ejca.2012.11.016
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Raghav Sundar, Udai Banerji, Juanita Lopez, Malaka Ameratunga, J.E. Ang, Maxime Chenard-Poirier, David Dolling, A.H. Ingles Garces, S. B. Kaye, J.S. de Bono
Publikováno v:
Annals of Oncology. 28:v422
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebb0d29edfbe88456f0fd0ac9b4112ca
https://doi.org/10.1093/annonc/mdx376.057
https://doi.org/10.1093/annonc/mdx376.057
Autor:
R. Pandher, Udai Banerji, Sarah K. Davies, S. B. Kaye, Debra J. Skene, Paul Workman, Suzanne A. Eccles, J.E. Ang, Florence I. Raynaud, J.S. de Bono, Yasmin Asad
Publikováno v:
European Journal of Cancer. 50:148-149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89631548d47b811d9c3bec5dade5aa28
https://doi.org/10.1016/s0959-8049(14)70579-9
https://doi.org/10.1016/s0959-8049(14)70579-9
Autor:
Sue E. Bell, Johann S. de Bono, Martina Uttenreuther-Fischer, J.E. Ang, Jan Adam, Peter Stephens, Laura Vidal, Mehdi Shahidi, Peter Stopfer, Ruth Plummer, James Spicer, Graham Temple, Andrew Futreal, Hilary Calvert, Heather Shaw, Timothy A. Yap
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(25)
Purpose Preclinical data have demonstrated that BIBW 2992 is a potent irreversible inhibitor of ErbB1 (EGFR/HER1) and mutated ErbB1 receptors including the T790M variant, as well as ErbB2 (HER2). A phase I study of continuous once-daily oral BIBW 299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd703a37a94d95a7ad35677d5e61eb8c
https://pubmed.ncbi.nlm.nih.gov/20679611
https://pubmed.ncbi.nlm.nih.gov/20679611
Publikováno v:
Journal of clinical pathology. 61(8)
The discovery of ETS gene fusions as common events in prostate cancer represents a paradigmatic shift in the significance attributed to chromosomal translocations as a key mechanistic player in carcinogenesis. However, these chromosomal fusion events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b721c81ef6ab649d2aef98aae4a980e
https://pubmed.ncbi.nlm.nih.gov/18495790
https://pubmed.ncbi.nlm.nih.gov/18495790
Autor:
Malcolm R Ranson, Sophie Callies, Michael Lahn, J. Davies, J.S. de Bono, Valerie Andre, J.E. Ang, D Talbot
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY. 26(15)
3518 Background: Survivin is a member of the inhibitors of apoptosis proteins (IAP) family, which are generally expressed in tumor but not in normal differentiated cells. LY2181308, a novel 2’-O-methoxymethyl modified anti-sense oligonucleotide (2-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8804b173b40c740dc0a589254051693e
http://ora.ox.ac.uk/objects/uuid:a3909014-8a94-463c-8d1e-24e909d8bc86
http://ora.ox.ac.uk/objects/uuid:a3909014-8a94-463c-8d1e-24e909d8bc86
Publikováno v:
Clinical Oncology. 27:e10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2bdc24bbe101badbdbf92e41b6b829e
https://doi.org/10.1016/j.clon.2015.01.014
https://doi.org/10.1016/j.clon.2015.01.014